AR049337A1 - 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina - Google Patents

7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina

Info

Publication number
AR049337A1
AR049337A1 ARP050101934A ARP050101934A AR049337A1 AR 049337 A1 AR049337 A1 AR 049337A1 AR P050101934 A ARP050101934 A AR P050101934A AR P050101934 A ARP050101934 A AR P050101934A AR 049337 A1 AR049337 A1 AR 049337A1
Authority
AR
Argentina
Prior art keywords
group
linear
branched
phe
integer
Prior art date
Application number
ARP050101934A
Other languages
English (en)
Spanish (es)
Inventor
Pozzo Alma Dal
Ming Hong Ni
Sergio Penco
Lucio Merlini
Valle Sabrina Dalla
Giuseppe Giannini
Maria Ornella Tinti
Claudio Pisano
Domenico Alloatti
Loredana Vesci
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of AR049337A1 publication Critical patent/AR049337A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP050101934A 2004-05-13 2005-05-12 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina AR049337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000242A ITRM20040242A1 (it) 2004-05-13 2004-05-13 "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.

Publications (1)

Publication Number Publication Date
AR049337A1 true AR049337A1 (es) 2006-07-19

Family

ID=35124315

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101934A AR049337A1 (es) 2004-05-13 2005-05-12 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina

Country Status (12)

Country Link
US (1) US7589099B2 (https=)
EP (1) EP1747020A2 (https=)
JP (1) JP2007537243A (https=)
CN (1) CN101065150A (https=)
AR (1) AR049337A1 (https=)
AU (1) AU2005243883A1 (https=)
BR (1) BRPI0511077A (https=)
CA (1) CA2562569A1 (https=)
IT (1) ITRM20040242A1 (https=)
MX (1) MXPA06012885A (https=)
TW (1) TW200538123A (https=)
WO (1) WO2005110486A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
WO2011086553A1 (en) * 2010-01-13 2011-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules
CN103275094B (zh) * 2013-05-08 2015-07-08 中国农业科学院植物保护研究所 (20s)-喜树碱的衍生物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
EP1044977B1 (en) * 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.

Also Published As

Publication number Publication date
CN101065150A (zh) 2007-10-31
US7589099B2 (en) 2009-09-15
MXPA06012885A (es) 2007-08-14
CA2562569A1 (en) 2005-11-24
EP1747020A2 (en) 2007-01-31
US20070225311A1 (en) 2007-09-27
BRPI0511077A (pt) 2007-12-26
AU2005243883A1 (en) 2005-11-24
WO2005110486A3 (en) 2007-03-08
TW200538123A (en) 2005-12-01
JP2007537243A (ja) 2007-12-20
ITRM20040242A1 (it) 2004-08-13
WO2005110486A2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
ECSP088246A (es) Nuevos derivados de benzotiazolona
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
AR047928A1 (es) Derivados de tetrahidropiridoindol
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ATE457781T1 (de) Orale zusammensetzungen mit extrakten von rosmarin und zugehörige verfahren
CY1113267T1 (el) Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
BRPI0515316A (pt) compostos de imidazoquinolina
AR035285A1 (es) Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion.
BRPI0513460A (pt) composição aquosa suave apropriada para a limpeza do cabelo e da pele
BR0116168A (pt) Formulação repelente de inseto liberável por dispositivo piezelétrico
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
ECSP066950A (es) Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2
CY1111983T1 (el) Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο
BR0211995A (pt) Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
KR102560772B9 (ko) 신규한 이온화지질 및 이를 이용한 지질나노입자 조성물
CL2008002429A1 (es) Compuestos derivados de n-bencil, n'-arilcarbonilpiperazina, con actividad agonista de los receptores x del higado (lxrs); composicion farmaceutica que los contiene; y el uso de los compuestos en el tratamiento de la aterosclerosis.
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
AR048949A1 (es) Camptotecina conjugada en posicion 7 con antagonistas de la integrina
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR049337A1 (es) 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal